Department of Otolaryngology–Head and Neck Surgery, University of Western Ontario, London, ON.
J Otolaryngol Head Neck Surg. 2012 Apr;41 Suppl 1:S49-55.
To assess patient adherence to nasal spray regimens after endoscopic sinus surgery (ESS) and to study factors that predict adherence.
A three-arm, randomized, blinded, controlled trial was conducted at a tertiary care academic hospital, studied via a prospective longitudinal survey, of 60 consecutive chronic rhinosinusitis patients managed with ESS and started on one of three postoperative nasal spray regimens. Structured telephone interviews were conducted after surgery over a 12-month period using a validated questionnaire that assessed both spray adherence and barriers to adherence. Patient demographics, time post-ESS, preoperative Sino-Nasal Outcome Test (SNOT) scores, Lund-Mackay scores, adherence risk factors, and polyp grades were used as covariates with logistic regression.
Overall, 57.4% of patients were nonadherent. Logistic regression showed that preoperative SNOT scores (p = .018, 95% CI = 0.84-0.98), time post-ESS (p = .016, 95% CI = 1.02-1.22), and the presence of an adherence risk factor (p = .03, 95% CI = 1.18-26.99) significantly predicted whether a patient was adherent and correctly classified 70.4% of all patients. Age, gender, and nasal spray regimen did not predict adherence (p > .05).
The majority of patients were nonadherent to post-ESS nasal sprays, irrespective of which nasal spray regimen they were on. Preoperative SNOT scores, time post-ESS, and the presence of an adherence risk factor predicted adherence. With this knowledge, otolaryngologists can selectively employ strategies to improve adherence in high-risk patients and possibly improve ESS outcomes.
评估内镜鼻窦手术后(ESS)患者对鼻腔喷雾剂方案的依从性,并研究预测依从性的因素。
在一家三级保健学术医院进行了一项三臂、随机、盲法、对照试验,通过前瞻性纵向调查,对 60 例连续接受 ESS 治疗并开始使用三种术后鼻腔喷雾剂方案之一的慢性鼻-鼻窦炎患者进行研究。在术后 12 个月内,通过使用评估喷雾依从性和依从性障碍的有效问卷,进行了结构化的电话访谈。患者的人口统计学资料、ESS 后时间、术前鼻窦-鼻息肉结局测试(SNOT)评分、Lund-Mackay 评分、依从性危险因素和息肉分级被用作协变量,进行逻辑回归分析。
总体而言,57.4%的患者不依从。逻辑回归显示,术前 SNOT 评分(p =.018,95%CI = 0.84-0.98)、ESS 后时间(p =.016,95%CI = 1.02-1.22)和存在依从性危险因素(p =.03,95%CI = 1.18-26.99)显著预测了患者是否依从,并正确分类了 70.4%的所有患者。年龄、性别和鼻腔喷雾剂方案不预测依从性(p >.05)。
大多数患者在接受 ESS 后不依从鼻腔喷雾剂,无论他们使用哪种鼻腔喷雾剂方案。术前 SNOT 评分、ESS 后时间和存在依从性危险因素预测了依从性。有了这些知识,耳鼻喉科医生可以有针对性地采取策略,提高高风险患者的依从性,并可能改善 ESS 结局。